Toth Financial Advisory’s Biogen BIIB Stock Holding History

Toth Financial Advisory’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.16K	Hold	10	–	–	﹤0.01%	743
2026 Q1	$1.83K	Buy	+10	New	+$1.84K	﹤0.01%	729
2023 Q2	–	Sell	-7	Closed	-$1.95K	–	788
2023 Q1	$1.95K	Buy	+7	New	+$1.94K	﹤0.01%	656
2021 Q4	–	Sell	-36	Closed	-$10K	–	759
2021 Q3	$10K	Buy	+36	New	+$11.8K	﹤0.01%	475
2020 Q4	–	Sell	-8	Closed	-$2K	–	597
2020 Q3	$2K	Hold	8	–	–	﹤0.01%	469
2020 Q2	$2K	Hold	8	–	–	﹤0.01%	458
2020 Q1	$3K	Hold	8	–	–	﹤0.01%	359
2019 Q4	$2K	Buy	+8	New	+$2.22K	﹤0.01%	407
2019 Q1	–	Sell	-10	Closed	-$3K	–	418
2018 Q4	$3K	Hold	10	–	–	﹤0.01%	356
2018 Q3	$4K	Buy	+10	New	+$3.44K	﹤0.01%	368
2018 Q1	–	Sell	-10	Closed	-$3K	–	427
2017 Q4	$3K	Buy	+10	New	+$3.21K	﹤0.01%	377

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Toth Financial Advisory's BIIB Position: Q2 2026 in Review

Toth Financial Advisory held its Biogen (BIIB) position steady in Q2 2026 at 10 shares worth $2.16K. The position accounts for ﹤0.01% of the portfolio, ranked #743.

Toth Financial Advisory first reported a position in BIIB in Q4 2017 and has held it in 11 quarters since. The position peaked at $10K in Q3 2021. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Toth Financial Advisory held 10 shares of Biogen worth $2.16K as of Q2 2026.
Toth Financial Advisory left its Biogen share count unchanged in Q2 2026.
Biogen made up ﹤0.01% of Toth Financial Advisory's portfolio in Q2 2026, its #743 holding.
Toth Financial Advisory first reported a position in Biogen in Q4 2017 and has held it in 11 quarters since.
Toth Financial Advisory's Biogen position peaked at $10K in Q3 2021.
1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Toth Financial Advisory's 13F filing for Q2 2026, filed 14 Jul 2026.